Vranken, L. http://orcid.org/0000-0002-6925-4397
Wyers, C. E.
Van der Velde, R. Y.
Janzing, H. M.
Kaarsemaker, S.
Geusens, P. P.
Van den Bergh, J. P.
Funding for this research was provided by:
Maastricht University
Article History
Received: 26 June 2017
Accepted: 25 October 2017
First Online: 23 November 2017
Compliance with ethical standards
:
: Dr. Vranken declares that she has no conflict of interest.Dr. Wyers declares that she has no conflict of interest.Dr. Van der Velde declares that he has no conflict of interest.Dr. Janzing declares that he has no conflict of interest.Dr. Kaarsemaker declares that he has no conflict of interest.Dr. Geusens reports grants and other from Amgen, grants from Pfizer, grants from MSD, grants from UCB, grants from Abbott, grants and other from Lilly, grants from BMS, grants from Novartis, grants from Roche, and grants from Will Pharma, outside the submitted work.Dr. Van den Bergh reports grants from Amgen, grants from Will Pharma, and grants from Eli Lilly, outside the submitted work.